Health News Releases

  • Today February 18
November 04, 2016 10:15
Takeda to Present Broad Range of Clinical Data During 58th American Society of Hematology Annual Meeting
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present a total of 16 company-sponsored abstracts at the 58th American Society of Hematology (ASH) Annual Meeting taking
November 03, 2016 17:05
Medtronic Signs the “Open Data Pledge” to Share Data to Improve Patient Safety
The Patient Safety Movement Foundation (PSMF) today announced that Medtronic, a leading global healthcare solutions company, has joined a growing list of healthcare technology companies that have sign
November 02, 2016 18:00
Takeda Donates 1 Billion Yen as an Exclusive Partner to the United Nations Foundation for “Global Measles Vaccination for Children” Program
Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced that Takeda will exclusively support “Global Measles Vaccination for Children” by the United Nations Foundation’s Shot@Life campaign.
November 02, 2016 17:45
Takeda: CSR Programs Focusing on Maternal and Child Health
Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced that the company will implement three CSR programs focusing on solutions to maternal and child healthcare problems in Africa and Asia
November 02, 2016 11:05
Overall survival data from LUX-Lung 7 head-to-head trial of afatinib versus gefitinib presented at ESMO 2016
Boehringer Ingelheim today announced results from the LUX-Lung 7 trial that directly compared the efficacy and safety of second-generation EGFR-directed therapy afatinib* (Giotrif®) and first-generati
October 31, 2016 10:25
Takeda Reports First Half FY2016 Results and Raises Full Year Profit Guidance
Takeda Pharmaceutical Company Limited (TOKYO:4502): Strong first half results led by Growth Drivers · Underlying Revenue grew +7.4%, led by a +15.3% increase of Takeda's Growth Drivers (GI, Onc
October 29, 2016 03:00
Face the Facts: Stroke is Treatable
Every two seconds, someone in the world is having a stroke. Globally, stroke is the leading cause of disability and the second leading cause of death. The right stroke care can save lives, but glob
October 27, 2016 11:15
Boehringer Ingelheim’s adalimumab biosimilar candidate shows similar efficacy and safety profile to Humira® in pivotal Phase III study
Boehringer Ingelheim today announced top-line results from the pivotal Phase III clinical study of BI 695501, a biosimilar candidate to U.S.-licensed Humira® and EU approved Humira® (adalimumab). BI 6
October 25, 2016 13:30
Q2 Solutions Enhances Companion Diagnostics Capabilities in Collaboration with Illumina
Q2 Solutions, a global clinical trials laboratory services organization, today announced the expansion of its genomic companion diagnostics (CDx) capabilities. This comes as a result of an agreement b
October 19, 2016 17:55
World Federation of Societies of Anaesthesiologists (WFSA) Signs Commitment to Support Patient Safety Movement’s Mission of Zero Patient Deaths by 2020
The World Federation of Societies of Anaesthesiologists (WFSA) has signed a commitment to action and announced that it will support the Patient Safety Movement Foundation (PSMF) and its mission to eli
October 19, 2016 13:50
QuintilesIMS Wins Society for Clinical Research Sites’ 2016 Eagle Award
QuintilesIMS (NYSE:Q) announced today that it has been awarded the 2016 Eagle Award from the Society for Clinical Research Sites (SCRS) for the fourth consecutive year. Presented during the annual SCR
October 19, 2016 10:05
Takeda Showcases Continued Commitment in Hodgkin Lymphoma During 10th International Symposium on Hodgkin Lymphoma (ISHL)
Takeda Pharmaceutical Company Limited (TSE: 4502) will present data on ADCETRIS® (brentuximab vedotin) in Hodgkin lymphoma at the 10th International Symposium on Hodgkin Lymphoma (ISHL), October 22 -
October 17, 2016 11:15
Oral GED-0301 Phase 1b Results Show Clinical Remission and Endoscopic Response at Week 12 in Patients with Active Crohn’s Disease
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that data from a randomized, double-blind, multicenter, exploratory phase 1b study evaluati
October 14, 2016 17:55
QuintilesIMS Named 2016 Frost & Sullivan Asia Pacific CRO Company of the Year
QuintilesIMS today was named Asia Pacific Contract Research Organization (CRO) Company of the Year by Frost & Sullivan, a leading business research and consulting firm, because of its industry leaders
October 14, 2016 11:20
Celgene to Present New Data on Investigational Compounds at UEGW and ACG Congresses
Celgene Corporation (NASDAQ:CELG) today announced that findings from clinical trials of investigational compounds GED-0301 (mongersen), ozanimod and RPC4046 will be presented at the United European Ga
October 12, 2016 10:00
Mannatech’s Asia MannaFest℠ Event Fuels Company Momentum
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, is hosting its annual Asia MannaFest event at Olympic Park Handbal
October 11, 2016 17:25
Zymergen Announces $130 Million in Series B Funding, Led by SoftBank
Zymergen, a technology company unlocking the power of biology, announced today that it has raised 130 million USD in Series B funding led by SoftBank Group (TOKYO: 9984). The round also includes prior
October 11, 2016 10:50
Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m
Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody®-based therapeutics, and Takeda Pharmaceutical Company Limited (TSE: 4502) today announced a global, strategic, mu
October 11, 2016 10:45
Durvalumab Shows Promising Preliminary Early Data in Lung and Head & Neck Cancers
AstraZeneca and its global biologics research and development arm, MedImmune, announced today efficacy and safety data for durvalumab from two separate cohorts of patients with either advanced non-sma
October 10, 2016 09:30
Faslodex Demonstrates Progression-Free Survival Advantage in 1st Line Advanced Breast Cancer
AstraZeneca today announced data from the Phase III FALCON trial demonstrating superior median progression-free survival (PFS) for Faslodex (fulvestrant) 500mg compared to Arimidex (anastrozole) 1mg i
October 07, 2016 13:55
Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter®
Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97™ Pulse CO-Oximeter®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ SET® pulse oximetry and upgradeable rainbow SET
October 06, 2016 15:35
Herbalife Nutrition Asia Pacific Survey Reveals That Millennials Find It Difficult to Engage in Physical Activities in the Modern Workplace
Herbalife Nutrition, a global nutrition company, has released findings from its Asia Pacific Millennials At Work Survey[1], showing that younger workers in Asia want to do more physical exercise while
October 05, 2016 18:00
Cardinal Health Expands in Asia
Leading global, integrated healthcare services and products company, Cardinal Health (NYSE:CAH), today announced that it will bring its powder-free gloves product line to Hong Kong while further penet
October 05, 2016 16:00
IncellDx’s Quantitative Immuno-Oncology Assay OncoTect iO Published in New Study
IncellDx, Inc., a single cell, precision medicine company, today announced that the international peer-reviewed medical journal Cancer Immunology, Immunotherapy has published a manuscript entitled: “Q
October 04, 2016 21:00
Replicor to Disclose Late Breaking HBV Clinical Data at AASLD 2016
Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic hepatitis B and D patients, today announced that the preliminary interim analysis from its latest REP 401 clinica
25 per page50 per page75 per page100 per page